Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/47874
Title: Kidney replacement therapy for men and women according to the ERA Registry and the USRDS
Authors: Stel, Vianda S.
Chesnaye, Nicholas C.
Boenink, Rianne
Boerstra, Brittany A.
Astley, Megan E.
Methven, Shona
HEYLEN, Line 
Resic, Halima
Ten Dam, Marc A. G. J.
Hommel, Kristine
Solbu, Marit D.
Slon Roblero, Maria F.
Areste-Fosalba, Nuria
Radunovic, Danilo
Garcia Lopez, Hector
Buchwinkler, Lukas
Guidotti, Rebecca
Lassalle, Mathilde
Santiuste, Carmen
Stendahl, Maria
Indridason, Olafur S.
Escriba, Almudena
Bouzas-Caamano, Maria Encarnacion
Rodriguez Arevalo, Olga Lucia
Moustakas, George
Hernandez Vargas, Hermann
Ortiz, Alberto
Kramer, Anneke
Issue Date: 2025
Publisher: OXFORD UNIV PRESS
Source: Nephrology, dialysis, transplantation,
Status: Early view
Abstract: Background This article compares the incidence and prevalence of kidney replacement therapy (KRT), kidney transplantation rates and mortality on KRT between Europe and the USA, including sex comparisons.Methods Data were derived for 2022 from the population-based European Renal Association (ERA) Registry and the United States Renal Data System (USRDS).Results In 2022, the KRT incidence in the USA [388.7 per million population (pmp)] was 2.7-fold higher than in Europe (146.2 pmp), with a greater difference for women (3.2-fold) than for men (2.4-fold). The proportion of women initiating KRT was lower in Europe (35%) than in the USA (41%). Between 2013 and 2022, the KRT incidence in Europe was stable in women (+0.1% annually) but increased in men (+1.1%). In the USA, the KRT incidence increased similarly in women (+0.2%) and men (+0.3%). On 31 December 2022, the KRT prevalence was 2-fold (women 2.2-fold, men 1.9-fold) higher in the USA (2444.2 pmp) than in Europe (1218.6 pmp). The proportion of women was lower in Europe (38%) than in the USA (41%). The kidney transplantation rate was 1.7-fold higher in the USA (79.1 pmp) than in Europe (45.4 pmp), 1.9-fold for women and 1.7-fold for men, with women accounting for 37% of the recipients versus 39% in the USA. The KRT mortality rate was 1.5 times higher in the USA [145.0 per 1000 patient-years (py)] compared with Europe (100.5 per 1000 py): 1.6-fold for women and 1.4-fold for men. In Europe, mortality was lower for women receiving KRT (93.7 per 1000 py) than for men (104.6 per 1000 py), whereas in the USA the reverse was true (women 148.9 per 1000 py, men 142.2 per 1000 py).Conclusion The US had a notably higher KRT incidence, prevalence, kidney transplantation rate and mortality compared with Europe. Differences between Europe and the USA were larger for women than for men. 10.1093/ndt/gfaf233 Video Abstract Watch the video abstract of this contribution at https://academic.oup.com/ndt/pages/author_videos gfaf233Media1 6385755737112
Notes: Kramer, A (corresponding author), Univ Amsterdam, Dept Med Informat, ERA Registry, Amsterdam UMC Locat, Amsterdam, Netherlands.; Kramer, A (corresponding author), Amsterdam Publ Hlth Res Inst, Qual Care, Amsterdam, Netherlands.
a.kramer@amsterdamumc.nl
Keywords: epidemiology;incidence;kidney replacement therapy;mortality;prevalence
Document URI: http://hdl.handle.net/1942/47874
ISSN: 0931-0509
e-ISSN: 1460-2385
DOI: 10.1093/ndt/gfaf233
ISI #: 001627001500001
Rights: The Author(s) 2025. Published by Oxford University Press on behalf of the ERA. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Kidney replacement therapy for men and women according to the ERA Registry and the USRDS.pdfEarly view2.04 MBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.